Your browser doesn't support javascript.
loading
Corrigendum: Neoadjuvant tislelizumab combined with chemotherapy in locally advanced oral or oropharyngeal squamous cell carcinoma: a real-world retrospective study.
Wu, Wen-Jie; Liu, Qian; An, Pu-Gen; Wang, Lin; Zhang, Jian-Yun; Chen, Yan; Zhang, Tong; Zhang, Jie.
Afiliação
  • Wu WJ; Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing, China.
  • Liu Q; National Center of Stomatology & National Clinical Research Center for Oral Diseases, Beijing, China.
  • An PG; Central Laboratory, Peking University School and Hospital of Stomatology, Beijing, China.
  • Wang L; Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing, China.
  • Zhang JY; National Center of Stomatology & National Clinical Research Center for Oral Diseases, Beijing, China.
  • Chen Y; Central Laboratory, Peking University School and Hospital of Stomatology, Beijing, China.
  • Zhang T; Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing, China.
  • Zhang J; National Center of Stomatology & National Clinical Research Center for Oral Diseases, Beijing, China.
Front Immunol ; 14: 1346845, 2023.
Article em En | MEDLINE | ID: mdl-38250067
ABSTRACT
[This corrects the article DOI 10.3389/fimmu.2023.1282629.].
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article